Clinical trials: Sepsis-associated Liver Dysfunction
Liver Dysfunction
FC Change From Day 1 to Day 3 Associated With SALD
As defined by sepsis 3.0, sepsis is a clinical syndrome caused by disordered host response to serious infection，leading to multiple organ dysfunction1.
- Trial name
- 2024-04-22 (NCT06403553)
- Testing
- Fecal Calprotectin
- Where
- China
- Volunteers
- 96 people
- Sponsor
- Chinese Medical Association
Gut Microbiota, Intra-abdominal Infections
Gut Microbiota Analysis in IAI Patients With Sepsis-associated Liver Dysfunction
With the rapid development of intensive care medicine, the mortality of patients with sepsis has decreased over the past decade, but it is still the leading cause of death in intensive care unit (ICU).
- Conditions
- Gut Microbiota, Intra-abdominal Infections, Acute Gastrointestinal Injury, Sepsis-associated Liver Dysfunction
- Trial name
- 2022-11-09 (NCT05628493)
- Testing
- Gut microbiota Analysis
- Where
- China
- Volunteers
- 20 people
- Sponsor
- Chinese Medical Association
Liver Dysfunction, Sepsis-associated Liver Dysfunction
Elevated Initial APRI Value Was Associated With SALD
Sepsis, characterized by severe organ dysfunction related to a dysregulated immune response to infection, is often life-threatening in clinical settings.
- Trial name
- NCT05999331
- Testing
- initial aspartate aminotransferase (AST) to platelet (PLT) ratio index
- Where
- China
- Volunteers
- 160 people
- Sponsor
- Chinese Medical Association